Sort
51,593 grants matching “hepatitis”
Investigating the partitioning of glucose to lipids versus respiration, an undergraduate-based approach to dissect a pivotal point of metabolic control
$437,614Julianne H. Grose · Brigham Young University · R15 · FY2020 · GM
Mouse Models of Insulin Resistance
$437,601Columbia University Health Sciences · R01 · FY2005 · DK
Functional Genomics Laboratory (FGL)
$437,581Anton Simeonov · National Center For Advancing Translational Sciences · ZIC · FY2021 · TR
TRIM mediated host antiviral responses during influenza virus infections
$437,546Adolfo Garcia-Sastre · University Of Southern California · U19 · FY2009 · AI
Novel Pharmacological Strategies for Liver Disease in Antitrypsin Deficiency
$437,522David H Perlmutter · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · DK
Mouse Models of Insulin Resistance
$437,518Domenico Accili · Columbia University Health Sciences · R01 · FY2006 · DK
Project 4-Early Liver Transplantation for Severe Alcoholic Hepatitis: Animal Studies
$437,511Zhaoli Sun · Johns Hopkins University · P50 · FY2025 · AA
Project 4-Early Liver Transplantation for Severe Alcoholic Hepatitis: Animal Studies
$437,511Zhaoli Sun · Johns Hopkins University · P50 · FY2024 · AA
Extracellular Vesicles in Alcoholic Liver Disease: Basic and Pre-Clinical Discovery
$437,500Gyongyi Szabo · Beth Israel Deaconess Medical Center · UH3 · FY2020 · AA
Molecular Mechanisms of Lipase Maturation and Secretion
$437,500Miklos Peterfy · Cedars-Sinai Medical Center · R01 · FY2015 · HL
A Chromosome 10 QTL Associated with IGF-1 and Bone Mass
$437,496Clifford J Rosen · Mainehealth · R01 · FY2010 · AR
Interplay between metabolism and FXR activation in scoparone signaling
$437,475Bingfang Yan · University Of Rhode Island · R15 · FY2013 · AT
Relaxin receptor agonists for treatment of liver fibrosis
$437,423Alexander I. Agoulnik · Florida International University · R01 · FY2019 · DK
IFN-I production in vivo for resistance to acute disseminating viral Infections
$437,417Luis J. Sigal · Thomas Jefferson University · R56 · FY2021 · AI
Immune Responses to Biodefense Vaccines Early in Life
$437,396Marcela F Pasetti · University Of Maryland Baltimore · R01 · FY2009 · AI
Treatment of Pulmonary Edema in Organ Donors
$437,279Lorraine B Ware · Vanderbilt University · R01 · FY2011 · HL
HEPATIC METABOLISM OF DIET DERIVED LIPOPROTIENS
$437,235Palo Alto Medical Foundation Res Inst · R01 · FY2002 · DK
Role of NF-kB-induce kinase (NIK) in liver diseases
$437,176Liangyou Rui · University Of Michigan At Ann Arbor · R01 · FY2018 · DK
Role of NF-kB-induce kinase (NIK) in liver diseases
$437,176Liangyou Rui · University Of Michigan At Ann Arbor · R01 · FY2019 · DK
Role of NF-kB-induce kinase (NIK) in liver diseases
$437,176Liangyou Rui · University Of Michigan At Ann Arbor · R01 · FY2020 · DK
Multi-level Evaluation of Racial/ethnic Disparities in Liver Disease Outcomes
$437,152Fasiha Kanwal · Baylor College Of Medicine · R01 · FY2024 · CA
Mechanisms of hepatitis C virus persistence
$437,150Arash Grakoui · Emory University · R56 · FY2011 · AI
Defining the intrahepatic immune response to hepatitis C virus
$437,150Arash Grakoui · Emory University · R01 · FY2010 · DK
Antiviral actions of interferons
$437,142Ganes C. Sen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · CA
A molecular basis for control of T cell memory
$437,102Stephen M Hedrick · University Of California, San Diego · R01 · FY2013 · AI